Markus Eisele

Markus Eisele is an experienced professional in regulatory CMC and quality control within the biopharmaceutical sector, currently serving as Manager Regulatory CMC Drug Substance at Formycon AG since January 2024. Previously, Markus held the position of Quality Control Manager at Pieris Pharmaceuticals from September 2021 to December 2023, focusing on quality oversight, GMP compliance, and various aspects of stability studies and method validation. Markus's academic background includes significant research roles at Ludwig-Maximilians Universität München and the Max Planck Institute of Biochemistry, along with a visiting research scientist position at Yale University. Markus earned a Dr. rer. nat. in Chemistry from the Technical University of Munich, a Master's degree in Technische Biologie from the University of Stuttgart, and a Bachelor's degree in the same field.